Status: Recruiting
A Study of CDX-622 in Participants With Mild to Moderate Asthma
This is a study to determine the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of CDX-622 in adults with mild to moderate asthma.
Participants needed: 12
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Celldex TherapeuticsUpdated: Jul 2, 2026Locations: 4
Eligibility criteria
Males and females, ≥ 18 years of age [+5]
Females who are pregnant or nursing [+10]